Metabolic alternation in cancer cells is one of the most common characteristics that distinguish malignant cells from normal cells. Many studies have explained the Warburg hypothesis that cancer cells obtain more energy from aerobic glycolysis than mitochondrial respiration. Here, we show that a branched-chain C-20 polyunsaturated fatty acid, geranylgeranoic acid (GGA), induces upregulation of the cellular protein levels of TP53-induced glycolysis and apoptosis regulator (TIGAR) and synthesis of cytochrome c oxidase 2 (SCO2) in human hepatoma-derived HuH-7 cells harboring the mutant TP53 gene, suggesting that GGA may shift an energetic state of the tumor cells from aerobic glycolysis to mitochondrial respiration. In addition, UPLC/TOF/MS-based metabolomics analysis supported the GGA-induced energetic shift, as it revealed that GGA induced a time-dependent increase in the cellular contents of fructose 6-phosphate and decrease of fructose 1,6-diphosphate. Furthermore, metabolomics analysis revealed that GGA rapidly induced spermine accumulation with slight decrease of spermidine. Taken together, the present study strongly suggests that GGA may shift HuH-7 cells from aerobic glycolysis to mitochondrial respiration through the immediate upregulation of TIGAR and SCO2 protein levels.
The transcription factor p53 responds to diverse stresses (including DNA damage, overexpressed oncogenes and various metabolic limitations) to regulate many target genes that induce cell-cycle arrest (e.g. p21) or apoptosis (e.g. PUMA) (30) . Among p53-target genes, another cell-death-related gene, the TIGAR (TP53-induced glycolysis and apoptosis regulator) gene is regulated as a part of the p53 tumor suppressor pathway and encodes a protein with sequence similarity to the bisphosphatase domain of the glycolytic enzyme, fructose 2,6-bisphosphatase that degrades fructose 2,6-bisphosphate (F2,6-DP) to fructose 6-phosphate (F6-P) (3) . The protein functions to block glycolysis and instead the resultant accumulated glucose 6-phosphate directs the pathway into the pentose phosphate shunt, which provides antioxidant electron donor NADPH. Therefore, expression of the TIGAR protein also protects cells from DNA-damaging reactive oxygen species (ROS) and thereby from DNA damage-induced apoptosis (2) . Furthermore, one novel gene that potentially links p53 to aerobic respiration was found in a group of p53-target genes (4, 5, 12) . The authors have identified SCO2 (Synthesis of cytochrome c oxidase 2) as a target for activation by p53 (12) . Upon discovering that p53 +/+ mice consumed significantly more oxygen and produced more ATP by aerobic respiration than their p53 −/− counterparts, the authors conducted a SAGE (serial analysis of gene expression) database search for potential p53-target gene products that could potentially modulate the process of aerobic respiration. And the protein is required for the proper assembly of the cytochrome c oxidase com-lack functional p53 represent a metabolic shift from aerobic respiration to glycolysis for the production of cellular energy and lower oxygen consumption by mitochondrial respiration-thereby contributing to the Warburg effect (10) . The metabolic change known as the Warburg effect is a major feature of virtually all clinical cancers (10) . In other words, unlike most normal cells, cancer cells acquire a mode of dependency on glycolysis for energy production. Although for many years the Warburg effect has been considered to be a by-product or just accompanying phenomenon of the oncogenic process, this shift to high rates of glycolysis is suggested to be required for malignant progression (9) . In this context, it is very important for cancer chemoprevention to induce metabolic shift from glycolysis to aerobic respiration in tumor cells. In general, it seems likely that activation of p53-dependent cell death can contribute to inhibition of cancer development at several stages during tumorigenesis (16) , and the p53 pathway is expected to be crucial for effective tumor suppression in humans (13) . This may be true also in tumor cells with p53 mutation. Indeed, even in HuH-7 cells harboring the mutant TP53 gene, we found that the mutant p53 was involved in GGA-induced cell death of HuH-7 cells by showing GGA-induced nuclear translocation of the mutant cytoplasmic p53 (7) . Knockdown of the TP53 gene with siRNA or blockage of the nuclear translocation of p53 with a small molecular weight drug of ivermectin significantly attenuated GGA-induced cell death (7) . Hence, in this study, to clarify a molecular mechanism of GGA-induced cell death in the mutant TP53 gene-harboring cells, we focused our attention on p53-target, energy metabolism-related genes, SCO2 and TIGAR in HuH-7 cells after GGA treatment. As a result, we found a rapid increase in the cellular levels of SCO2 and TIGAR by western blotting without upregulation of their transcript levels. Furthermore, metabolomics analysis revealed GGA-induced upregulation of cellular F6-P and NADH levels and downregulation of D-fructose 1,6-bisphosphate (F1,6-DP).
MATERIALS AND METHODS
Materials. GGA and farnesoic acid (FA) were generous gifts from Kuraray (Okayama, Japan). Geranylgeraniol (GGOH), D-fructose 6-phosphate (F6-P) dipotassium salt, D-fructose 1,6-bisphosphate (F1,6-DP) trisodium salt hydrate, phosphoenolpyruvic acid (PEP) monopotassium salt, and β-nicotinamide adeplex (COX) that is directly responsible for the reduction of oxygen during aerobic respiration. Geranylgeranoic acid (GGA) consists of 4-isoprene units in a straight chain, has a carboxylic group at its terminus and is categorized in acyclic diterpenoids found in several medicinal herbs including turmeric (28) . And we recently reported a possible mechanism that GGA could be biosynthesized from mevalonate pathway even in mammalian cells (15) . In the past two decades, 4,5-didehydroGGA has been proven to suppress carcinogenesis in experimental animals (17) , and to be an efficient chemical to prevent post-operative patients against second primary hepatoma in a phase II clinical trial (18, 20) , which has recently been further confirmed in a multicenter, randomized, double-blind, placebocontrolled study with a dose-dependent manner (23, 24) . GGA and 4,5-didehydroGGA were initially screened as acyclic retinoids to bind to the cellular retinoic acid-binding protein (19) . Furthermore, both compounds were later shown to possess ligand activities for retinoid receptors (retinoic acid receptor and retinoid X-activated receptor) (1). In human hepatoma-derived HuH-7 cells, GGA-induced cell death has so far been illustrated by at least 3 lines of evidence; 1) the chromatin condensation, 2) large-scale DNA fragmentations and nucleosomal-scale ladder formation, and 3) dissipation of mitochondrial inner membrane potential (ΔΨm) (21, 27) . It was also reported that some caspase inhibitors delayed GGAinduced cell death and, furthermore, α-tocopherol prevented HuH-7 cells from dissipation of ΔΨm as well as cell death in the presence of GGA. Importantly, GGA induced a dramatic loss of ΔΨm in a dose-and time-dependent manner in HuH-7 cells, but not in the primary hepatocytes (27) . Recently, we have reported that GGA induces an incomplete autophagic response in HuH-7 cells, which may be linked to GGA-induced cell death (22) . In most cancer cells, the tumor suppressor TP53 gene is modified through mutations or changes in its expression. However, the frequencies of reported TP53 mutations vary considerably between cancer types, ranging from ~10% (for example, in cervical malignancies) to 50-70% (for example, in hepatic, ovarian, colorectal and head and neck cancers) (26) . It has also been well established that human hepatoma-derived HuH-7 cells possess the mutant TP53 gene with a missense mutation of Y220C in the DNA-binding domain of p53 (6) . As mentioned above, p53 is involved both in TIGAR-mediated suppression of glycolysis and in SCO2-mediated enhancement of aerobic respiration, so that cells that of phosphate-buffered saline (PBS(−)), scraped off with lysis buffer of the kit S, and transferred into each 1.5-mL tubes. Then, the cells were homogenized by 1-mL syringe with a 21-G needle. Total cellular RNA was purified with nucleic acid isolation system, QuickGene-800 (Fujifilm). Total RNA was quantified by absorbance at 260 nm with NanoDrop ® spectrophotometer ND-1000 (NanoDrop Technologies, Wilmington, DE, USA), and 260 : 280 nm ratio was used as index of purity. The integrity of RNA preparations was further confirmed by electrophoresis in a denaturing agarose gel containing 1% formaldehyde and 1 × MOPS [3-(N-morpholinopropanesulfonic) acid] running buffer to detect 2 major rRNAs of 28S and 18S. After confirmation of the integrity, a preparation of total RNA was kept frozen at −20°C until use for reverse transcription polymerase chain reaction (RT-PCR).
Reverse transcription for cDNA synthesis. The aliquot corresponding to 300 ng of total cellular RNA of each sample, water (PCR-grade) and random hexamer primer included in Transcriptor ® first strand cDNA synthesis kit (Roche, Diagnostics, Mannheim, Germany) were incubated at 65°C for 10 min. To the mixture 5 × Transcriptor ® RT reaction buffer, Protector ® RNase inhibitor, deoxynucleotide mix and Transcriptor ® reverse transcriptase were added and incubated at 25°C for 10 min, at 55°C for 30 min, at 85°C for 5 min and at 4°C for over 5 min.
Quantitative PCR with cDNA. Nucleotide sequences of the primers including the SCO2, TIGAR and 28S rRNA cDNAs are listed in Supplementary Table 1 . Real-time PCR was performed with 9 μL reaction mixture containing 1 μL of primer solution (0.5 μM, the stock solution was diluted by 1 : 10), 5 μL of 2 × DyNAmo™ Capillary SYBR ® Green qPCR master mix (Finnzymes, Espoo, Finland) and 1 μL of cDNA containing solution in a PCR-capillary (Roche). The mixture was incubated in a LightCycler1.5 (Roche) under condition described in Supplementary  Table 2 .
Extraction of metabolites. Cells were inoculated in 9-cm dishes at 2.5 × 10 6 cells/dish. After 0, 2, 4, 8 or 24-h incubation with 10 μM GGA, the cells were quenched by replacement of the conditioned medium with 12 mL of ice-cold 0.9% (w/v) NaCl for 5 min, washed twice with 6 mL of PBS(−) and scraped off twice with 0.6 mL of PBS(−) on ice. The scraped cells were transferred into 2-mL tube by pipetting and centrifuged at 200 × g for 6 min at 0°C. Cell nine dinucleotide, reduced (NADH) disodium salt hydrate were all purchased from Sigma Aldrich, St. Louis, MO, USA.
Cell culture. Human hepatoma-derived HuH-7 cells were obtained from RIKEN BioResource Center, Tsukuba, Japan, and cultured in high-glucose Dulbecco's modified Eagle's medium (D-MEM; Wako Pure Chemical Industries, Osaka, Japan) supplemented with 5% fetal bovine serum (FBS; Hyclone Laboratories, ThermoFisher Scientific, Waltham, MA, USA).
GGA, GGOH or FA treatment. 3.0 × 10 4 cells were inoculated in 3-cm dishes (ThermoFisher Scientific, Nunc, Roskilde, Denmark) and cultured with D-MEM containing 5% FBS for 2 days, thereafter the medium was replaced with FBS-free D-MEM a day before GGA, ethanol, GGOH or FA addition. The ethanolic solution of GGA, GGOH or FA (2.5-50 mM) was added at a final concentration of 2.5-50 μM. Ethanol was added as a negative control at its final concentration of 0.1% (v/v).
Immunoblotting. Following treatment with GGA, GGOH or FA, HuH-7 cells were lysed with cell lysis buffer (Tris-based buffered saline containing 1% Nonidet P40, 0.5% sodium deoxycholate and 0.1% SDS) containing complete mini protease inhibitor cocktail (Roche Diagnostics, Basel, Switzerland) and proteins were quantified by Bradford assay (Bio-Rad, Hercules, CA, USA). Equal amounts (2.5 or 5 μg) of protein per sample were separated by SDS-PAGE. The semi-dry blotted polyvinylidene fluoride membranes (Bio-Rad) were probed with anti-TIGAR polyclonal antibody (#37910; Abcam, Cambridge, MA, USA), anti-SCO2 polyclonal antibody (#54654; Anaspec, San Jose, CA, USA), anti-COX2 monoclonal antibody (#65239; Santa Cruz, CA, USA), anti-Porin polyclonal antibody (#548; Calbiochem, Merck, Tokyo, Japan) or anti-β-actin polyclonal antibody (#4967; Cell Signaling Technology, Boston, MA, USA). Horseradish peroxidase (HRP)-labeled secondary antibody (GE Healthcare, Tokyo, Japan) was detected with Immobilon Western Chemiluminescent HRP substrate (Merck Millipore Japan, Tokyo, Japan) using an ImageQuant LAS 4000 (GE Healthcare).
Isolation of total cellular RNA. After drug treatment, total RNA was isolated from cells by using QuickGene RNA cultured Cell kit S (Fujifilm, Tokyo, Japan). Cells in 3-cm dishes were washed with 2 mL time operating in either positive or negative ion modes. The nebulization gas was set to 800 L/h at a temperature of 450°C, and the cone gas was set to 50 L/h. Source temperature was set to 120°C. The capillary voltage and cone voltage were set to 3000 V and 30 V, respectively. The voltage of the MCP (multi-channel plate) detector was set to 2150 V. The data acquisition rate was set to 0.2 s. Data were recorded between m/z 80 to 1000 in centroid mode.
UPLC/Q-Tof Mass spectrometric measurement of F6-P, F1,6-DP, PEP and NADH.
The authentic m/z and retention times were obtained with 10 μM each standard solution on Waters UPLC/Q-Tof/MS apparatus as shown in Supplementary Table 3 . As described below, the obtained data from UPLC/Q-Tof/ MS for each metabolite were transformed by calculating the validated metabolite contents on a 10 6 cellular basis.
Data collection, processing and multivariate statistical analysis. Raw chromatogram data of UPLC/QTof/MS were initially converted to NetCDF (network common data file) formatted by Databridge in software of MarkerLynx ® (Waters). The peak width at 50% height was set to 3 s. Other parameters were all in default settings. Detected and matched peaks with retention time and m/z, and their corresponding intensities were electronically exported to an excel table. Prior to multivariate data analysis, the raw data of each sample was normalized to total masssignal area to correct for the MS response shift from the first injection to the last injection. To reproduce the difference in metabolites from between GGA-treated and ethanol-treated control HuH-7 cells, multivariate statistical analysis was performed using MarkerLynx ® XS software (Waters). Principal component analysis (PCA) and orthogonal partial least squares-discriminant analysis (OPLS-DA) models were constructed. Cross validation was used to calculate the number of significant components. Potential biomarkers for GGA-treated cells were selected according to variable importance in the projection (VIP) value of more than 1 (1>) in the S-plot. Statistical analysis was carried out using PASW Statistics 18 (SPSS Japan, Tokyo, Japan). Differences were considered statistically significant if P value was <0.05.
DNA measurement. The cell precipitates, mentioned above, were suspended by 10 mM Tris-HCl, pH 7.4 pellets were re-suspended in 1 mL of ice-cold 50% (v/v) aqueous acetonitrile (LC-MS Chromatosolv ® ; Fluka, Sigma-Aldrich), and the cell suspensions were agitated for 30 s by vortexing twice. The suspensions were centrifuged at 19300 × g for 8 min (at 0°C), and precipitates were used for DNA measurement with SYBR Green, and the supernatants were transferred to new 1.5-mL tubes, frozen at −80°C, and dried on the following day using a vacuum evaporator centrifuge, VEC-100 (Iwaki, Tokyo, Japan) equipped with a vapor trap of dry-ice/ethanol. The dried extracts were re-suspended in water and incubated on ice with frequent periods (30 s × 5) with bath-type sonication. After centrifuging the cell extracts at 19300 × g for 8 min at 0°C, the supernatants were transferred to new 2-mL tubes and stored frozen at −80°C until analysis. Samples were thawed out on ice and their aliquots were transferred to 0.3-mL screw-capped vial with pre-slit septum (Nihon Waters, Tokyo, Japan) filtered through a 0.2-μm pore-size membrane (Millipore Japan, Tokyo, Japan), and analyzed by ultraperformance liquid chromatography (UPLC) and quadrupole time-of-flight type mass spectrometric apparatus (Xevo™ Q-Tof/MS, Nihon Waters) described below.
UPLC. Reversed-phase chromatographic separation was performed on a 2.1 × 100 mm ACQUITY™ UPLC ® BEH C18, 1.7 μm column connected with the VanGuard pre-column (Waters). The column temperature was kept constant at 40°C. The mobile phase consisted of water containing 0.1% formic acid (Wako, HPLC grade) as solvent A and acetonitrile (LC-MS Chromatosolv ® , Sigma-Aldrich) containing 0.1% formic acid as solvent B. The gradient duration was 20 min at a flow rate of 0.3 mL/min. From the start to 0.5 min, a volume proportion of acetonitrile in eluent was kept at 1% (A : B = 99 : 1, v/v) and linearly increased to 95% (A : B = 5 : 95) in 10 min at a constant flow rate. Then, acetonitrile (%B) was kept at 95% for 4 min. After that acetonitrile (%B) was reduced to 1% in 4 min and kept at that concentration for 5 min. A 10-μL aliquot of each sample was injected automatically onto the column. The same sample was injected three times each for either negative or positive ion recordings.
Q-Tof/MS. In-line mass spectrometry was performed on a Waters Xevo™ Q-Tof mass spectrometry apparatus (Waters MS Technologies, Manchester, UK), which was calibrated with sodium formate and locksprayed with Leu-encephalin (Nihon Waters) each and 1 mM EDTA buffer (TE) 1 mL, centrifuged at 19300 × g for 8 min at 0°C, and then the supernatants (100 μL) were diluted with TE (400 μL). 100 μL each of the mixture was put into each well of a 96-well plate. After adding SYBR ® Green solution to each well and applying the 96-well plate containing samples to a plate-shaker, DNA measurements were performed with 2030 ARVO™ X4 Multilabel Reader (PerkinElmer, Waltham, MA, USA) in duplicate in order to calculate each validated metabolite contents on cellular basis.
RESULTS

SCO2 protein was upregulated by GGA treatment
The SCO2 gene is one of the p53-target genes and its gene product is involved in respiratory function. First of all, we investigated time-dependent changes in the cellular levels of SCO2 protein after GGA treatment (Fig. 1A) . Treatment with 10 μM GGA led to detection of SCO2 protein at as early as 2 h and the protein became most evident at 8 h and decreased at 24 h following the treatment. Next we examined concentration dependence of GGA-induced upregulation of SCO2 protein. The cellular level of SCO2 protein was induced by 6-h incubation with GGA at as low as 2.5 μM and at concentrations of 10-50 μM the cellular SCO2 levels increased dramatically, although the cellular level of porin, a mitochondria-resident protein, did not show such a change (Fig. 1B) . As described above, the SCO2 gene is one of the p53-target genes, which means p53 is able to transactivate the SCO2 gene. Hence, we measured the cellular levels of the SCO2 gene transcript to dissect a mechanism of GGA-induced upregulation of SCO2 protein. However, cellular mRNA level of the SCO2 gene was not essentially induced by addition of GGA (supplementary Fig. 1A) .
Specificity for GGA in SCO2 protein upregulation
To examine chemical structure specificity for GGA to induce upregulation of the cellular SCO2 protein level in HuH-7 cells, we tested a couple of GGAanalogous compounds, GGOH and FA (chemical structures are shown in Fig. 1C, lower part) , at the same concentration of 10 μM for 16 h. As described above, GGA was repeatedly shown to induce upregulation of the cellular SCO2 protein level, whereas FA showed no activity and GGOH showed only slight activity for the upregulation (Fig. 1C) .
Specificity for SCO2 protein in GGA-induced upregulation
SCO2 is a copper-binding protein involved in formation of the CuA center of the mitochondria-genome encoded cytochrome c oxidase II (COX2 or MT-CO2) subunit as a metallo-chaperone with SCO1 (11) . So, we were also interested to examine GGAinduced changes in the cellular level of COX2. As shown in Fig. 2A, COX2 protein level was upregulated at as early as 2 h after GGA treatment and the Whole-cell lysates were prepared and SCO2 protein levels were analyzed by western blotting. β-Actin was used as a loading control. (B) HuH-7 cells were treated with or without GGA (2.5-50 μM) for 6 h. Whole-cell lysates were prepared and SCO2 levels were analyzed by western blotting. Porin was used as a loading control. (C) HuH-7cells were treated with or without 10 μM of GGA, GGOH or FA for 16 h, and SCO2 levels were analyzed by western blotting. Porin was used as a loading control. Fig. 2) , the OPLS-DA score plot clearly distinguished the GGA-treated group from control group in triplicate (Fig. 4A) . The S-plot analysis was performed to find potential biomarkers for GGA effects. As shown in Fig. 4B , S-plots apparently provide a visual representation of biomarker candidates for both groups. Especially, spots marked with red square mean important variables contributed for two-group discrimination. In the first quadrant (upper right), spots in a red square were selected as potent markers for GGA-treated cells. On the other hand, the third quadrant (lower left) included several spots in a red square as potent markers lost or decreased in GGA-treated cells. These markers selected by red squares show high score of reliability/responsiveness in the S-plot. Although all of these selected spots have been dropped into database survey connected to Internet (KEGG: Kyoto Encyclopedia of Genes and Genomes <http://www.genome.jp/kegg/>, HMDB: Human Metabolome Database <http://www.hmdb. ca/>, and ChemSpider <http://www.chemspider. com/>) in order to identify each metabolite, we are still in the middle of work identification of these biomarkers. Among the potent biomarkers suggested in the present study, a spot of 203.2221, indicated by a dark-gray arrow with an asterisk in Fig. 4B , was identified as spermine and a spot of spermine was detected as a potent biomarker also in 2 other pairwise comparisons between 0-h vs 4-h and between 0-h vs 8-h metabolites (dark-gray arrows with an asterisk indicate a spot of spermine in Supplementary  Fig. 3 ). Therefore, when we plotted along the signal intensity of the spermine peak area to the time after treatment with GGA, GGA was found to rapidly induce spermine (Fig. 5A) . Then, we searched a spot of spermidine, a direct precursor polyamine intermediate of spermine, by its protonated monoisotopic mass (m/z = 146.1657). As shown in Fig. 5B , although GGA upregulated the cellular content of spermine, the cellular content of spermidine rather decreased after GGA treatment.
DISCUSSION
In the present study, we found that HuH-7 cells upregulate the cellular protein levels of the SCO2 and TIGAR genes, both of which are p53-target genes, immediately after GGA treatment. Herein, we provide additional evidence to our previous finding that p53-target gene of PUMA is upregulated by GGA treatment in the mutant p53-expressing HuH-7 cells (7). Furthermore, GGA-induced metabolic shift from upregulated levels were maintained until 24 h. Cellular levels of TIGAR, another p53-target energy-metabolism related gene, were further assessed after GGA treatment. Fig. 2B clearly showed GGAinduced immediate upregulation of TIGAR protein level, but no induction was observed in its transcript level (supplementary Fig. 1B) , as in the case of SCO2 induction with GGA.
Upregulation of cellular F6-P level after GGA treatment
Next, we performed UPLC/Q-Tof/MS analyses to know how GGA-induced simultaneous upregulation of TIGAR, SCO2 and COX2 proteins, which mimic activation of p53, affects the cellular contents of glycolysis-related metabolites. As shown in Fig. 3 , we indeed found a time-dependent significant increase in the cellular contents of F6-P and a timedependent decrease in the cellular F1,6-DP contents in GGA-treated cells. The cellular contents of PEP fluctuated after GGA treatment. GGA-treated cells showed a time-dependent increase in the cellular content of NADH (Fig. 3) .
Metabolomics changes in GGA-treated cells
Then, we compared global metabolites between control and GGA-treated cells. Although total positive ion chromatograms of the cellular metabolites were apparently similar between 24-h GGA-treated cell extracts and 0-h control cell extracts ( Supplementary   Fig. 2 GGA-induced upregulation of the cellular COX2 and TIGAR protein levels. HuH-7 cells were treated with or without 10 μM GGA for 2, 4, 6, 8 and 24 h. Whole-cell lysates were prepared, and then COX2 (A) and TIGAR (B) levels were analyzed by western blotting. Either porin or β-actin was used as a loading control.
to survey metabolic alterations associated with GGAinduced upregulation of TIGAR and SCO2 protein.
At first, pair-wise comparison of several metabolites in metabolome was performed and then it was further validated by quantitative measurement on UPLC/QTof/MS analysis by using each authentic standard compounds. As a result, we found GGA-induced time-dependent increase of the cellular F6-P level and inversely decrease of the cellular F1,6-DP level, which is consistent with GGA-induced upregulation of TIGAR protein. In other words, these metabolic changes strongly suggest that GGA-induced TIGAR protein was expectedly active to decrease the cellular content of F1,6-DP through its bisphosphatase activity and consequently increase the cellular content of F6-P, indicating that GGA really works as glycolysis to aerobic respiration found in the present study is very important for cancer chemoprevention. Interestingly, GGA-induced upregulation of the SCO2 and TIGAR genes was found at their protein level but not at their mRNA level, although the PUMA gene is upregulated at its transcript level by GGA treatment (7) . Insofar as p53 plays a role as transcription factor in general, the reactivated p53 should enhance transcriptional rate of these genes. But we failed to detect any significant upregulation of these mRNA levels. Therefore, the upregulatory effects of GGA on p53-targeted genes of SCO2 and TIGAR should be post-transcriptional. Prior to further investigation of a molecular mechanism how GGA induces upregulation of the SCO2 and TIGAR genes at their protein level, we decided 6 cells) ± SD (n = 3) per cellular basis. All the P values were evaluated by t-test. *, P < 0.05, **, P < 0.01, ***, P < 0.001.
sis by catalyzing the hydrolysis of both F2,6-DP and F1,6-DP to F6-P (3, 5) . Furthermore, a pair-wise comparison of metabosuppressive to glycolysis through upregulation of TIGAR protein level. As described in Introduction section, TIGAR protein is known to inhibit glycoly- Hence, we speculate that GGA may shift cellular energy metabolism from glycolysis to citrate cycleaerobic respiration system. In this regard, we have reported important findings that GGA rapidly induces hyperproduction of mitochondrial superoxide and consequent dissipation of ΔΨm (22) . These previous observations, apparently contradictory to the enhanced aerobic respiration, might have better describe GGA-induced accumulation of the cellular NADH as well as GGA-induced cell death in HuH-7 cells. It is worth noting that metabolomics analysis is very powerful to identify a potential biomarker without any prediction. In the present study, global comparison of the cellular metabolites in HuH-7 cells after GGA treatment unexpectedly revealed that GGA rapidly and time-dependently upregulated the cellular content of spermine with significant decrease of spermidine. In general, polyamines such as spermine, spermidine and ornithine affect a plethora of cellular processes including transcription, translation, gene expression, autophagy and stress resistance and the regulation of polyamine levels is highly critical for the cell (14) . Although spermidine has an essential and unique role as the precursor for hypusine, which is an unusual amino acid and is found in post-translationally modified elongation factor eI-F5A, no unique role for spermine has so far been identified unequivocally (25) . Recently, chemically induced oxidative stress such as tert-butylhydroxyquinone or hydrogen peroxide treatment in HuH-7 cells was reported to increase spermine level in 18 h by activating the transcription of ornithine decarboxylase (ODC) and spermidine/spermine-N 1 -acetyltransferase (SSAT) (29) . As mentioned above, GGA also induces superoxide hyperproduction in HuH-7 cells (22) , hence, one can easily speculate that GGA may increase the spermine content via gene activation of these polyamine synthetic enzymes. However, the oxidative stressupregulated expression of the ODC and SSAT genes brought to increase also spermidine level (29) . Therefore, GGA-induced specific upregulation of spermine (spermidine was inversely downregulated after GGA treatment) may have a different mechanism from oxidative stress-induced upregulation of polyamines. Finally, we have to discuss how GGA upregulates the cellular SCO2 and TIGAR protein levels. The both gene products were upregulated by GGA treatment in a concentration and time-dependent manner (Figs. 1, 2) . Moreover the upregulation of SCO2 protein was rather specific for GGA. In other words, lomes and the following validation by UPLC/Q-Tof/ MS analysis revealed another important finding of GGA-induced upregulation of the cellular NADH level (Fig. 3) . In the present study, we did not analyze the subcellular distribution of NADH so that we are not aware how NADH was increased after GGA treatment, but we are able to speculate that GGA might enhance aerobic respiration, because GGA rapidly and efficiently upregulated both of the nuclear SCO2 and the mitochondrial COX2 gene products as shown in the present study. Mitochondrial electron transfer chain itself is NADH-consuming system, but it is highly linked to citrate cycle, which is an efficient NADH-producing system. Fig. 3 against 0-h control metabolome was performed with the protonated monoisotopic mass of 203.2236 for spermine (A) and 146.1657 for spermidine (B) and then the signal intensity of each peak area was plotted against time after GGA treatment. *, P < 0.05, **, P < 0.01, ***, P < 0.001.
GGOH slightly induced upregulation of SCO2 protein under the same conditions as GGA, and FA did not induce it at all. The specificity for GGA is similar to a specificity for GGA to induce the unfolded protein response (UPR) (8) . Hence, GGA-induced UPR may be involved in GGA-induced upregulation of both SCO2 and TIGAR proteins. In this context, we should investigate whether GGA is able to upregulate both proteins also in other hepatoma cell lines including HepG-2 (p53 wild type), PLC/PRF/5 (mutant p53 R249S) and Hep3B (p53 null) cells, because these cell lines are shown to be all sensitive to induce UPR upon GGA treatment (8) . On the other hand, we recently reported GGA-induced nuclear translocation of the cytoplasmic p53 in HuH-7 cells (mutant p53 Y220C) as well as in PLC/PRF/5 cells (7). So, we are also speculating that GGAinduced nuclear translocation of mutant p53 may be important to upregulate SCO2 and TIGAR protein.
In this case, HepG-2 and Hep3B cells are expected to be reluctant to upregulate SCO2 and TIGAR proteins after GGA treatment. In any case, further detailed investigation of a molecular mechanism is certainly required to know how GGA upregulates the cellular protein levels of these p53-target genes. In summary, first GGA induced upregulation of the TIGAR gene, which might inhibit the glycolysis in HuH-7 cells with p53 mutation. Second GGA also increased the SCO2 gene expression, which might enhance aerobic respiration. So we speculated GGA may repair the Warburg effect by inhibiting glycolysis and also enhancing oxygen respiration or shifting back to normal mode of energy metabolism in the p53-mutated cells. Third UPLC/Q-Tof/MSbased metabolomics analyses partially support this concept and have provided a working hypothesis that GGA may perturb polyamine metabolism. 
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